Breaking News

Lilly to Invest $5B in New Virginia Plant 

New site will develop APIs in the U.S. for cancer, autoimmune and other advanced therapies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lilly

Image courtesy of Lilly.

Lilly announced plans to invest $5 billion to build a new manufacturing facility west of Richmond, VA. The new site will be the company’s first dedicated, fully integrated active pharmaceutical ingredient (API) and drug product facility for Lilly’s emerging bioconjugate platform and monoclonal antibody portfolio. The investment expands domestic drug production and aims to circumvent potential tariffs. Earlier this year, the company announced plans to bolster its domestic medi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters